Written by Joshua Marcus, President of Marcus & Associates, a Life Sciences and Healthcare recruiting firm.
Most hiring leaders haven’t noticed yet.
The Q2 numbers:
Biopharma layoffs: down 59% year over year
Job postings: up 15%
Biotech R&D employment: above year-ago levels
Fewer cuts. More openings. That’s a market turning.
And the rebound is concentrated – Clinical, Regulatory, Quality, Manufacturing, pre-launch Commercial. Everyone needs the same specialists at the same time.
So counteroffers are back. Time-to-accept is shrinking. And candidates who lived through layoffs are careful – a slow, disorganized search reads as a slow, disorganized company.
Teams still hiring like it’s 2024 will spend Q4 wondering where the candidates went.
The advantage now goes to whoever is ready to move: clear role, tight process, strong close.
At Marcus & Associates, we help Life Sciences and Healthcare leaders run searches built for a competitive market.
If a critical hire can’t wait, message me here or visit www.marcusassoc.com/
Are candidates gaining leverage in your searches – or not yet in your specialty?
Source: BioSpace, 2026 Q2 Biopharma Job Market Report
#lifesciences #healthcare #pharma #biotech #hiring
Learn more at www.marcusassoc.com/

